Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of CGM Technology in Persons Living With Prediabetes
Sponsor: Wake Forest University Health Sciences
Summary
Continuous glucose monitor (CGM) technology has become increasingly prevalent in the population and has the ability to transform care of patients living with prediabetes. While the technology was initially utilized primarily by patients living with type 1 diabetes using insulin pump therapy, it has become more widely used as part of care in patients living with type 1 or 2 diabetes on any kind of insulin therapy.
Official title: Trial of Continuous Glucose Monitoring (CGM) Technology in Persons Living With Prediabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-10
Completion Date
2027-05
Last Updated
2026-08-27
Healthy Volunteers
No
Conditions
Interventions
Stelo CGM
The Stelo Glucose Biosensor is built on the most accurate continuous glucose monitoring technology from Dexcom and is simple and painless to apply. By sending glucose levels directly to your smartphone,\* it gives you just the right amount of information to work with.
Locations (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States